Has anyone with HER2+ breast cancer tried Enhertu treatment?

I have stage IV metastatic HER2-positive breast cancer. I just read about the FDA approving Enhertu (trastuzumab deruxtecan) for two new uses in earlier stages of breast cancer - both in the neoadjuvant setting for stage 2-3 patients and in the adjuvant setting for those with residual disease after initial treatment. While these specific approvals don't apply to my current situation since I have metastatic disease, it's encouraging to see this treatment expanding to help more patients. Enhertu is already approved for metastatic HER2-positive breast cancer like mine, so this news shows the continued success of a treatment that might be part of my care planning. I'd love to connect with others who have HER2-positive breast cancer at any stage: • Have you or your care team discussed Enhertu as a treatment option? • What has your experience been with HER2-targeted treatments in general? Link: https://markets.businessinsider.com/news/stocks/fda-approves-enhertu-for-two-new-breast-cancer-indications-1036166013